Immunosuppressive effects of barbituric acid derivatives. II. Effect of 1.3-bis(piperidinomethyl)-5-ethyl-5-phenyl-barbituric acid on humoral and cell-mediated immunity in mice.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology; D001463:Barbiturates / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents; D007668:Kidney / Q000502:physiology; D007674:Kidney Diseases / Q000276:immunology; D007678:Kidney Glomerulus / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008814:Mice, Inbred NZB; D009392:Nephrectomy; D016038:Skin Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous; D005719:gamma-Globulins / Q000032:analysis
D000906:Antibodies; D001463:Barbiturates; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D003520:Cyclophosphamide